Studies have shown that type 2 innate lymphoid cells are enriched in prostate cancer,30 which produce interleukin (IL)-4 and IL-13, and are known to regulate tumor microenvironment and promote cancer proliferation.31 The gene discussed is IL13; the disease is prostate carcinoma.